# China Perfusion Radiology Market > China Perfusion Radiology Market Research Report By Application (Cardiovascular Imaging, Ventilation Imaging, Brain Imaging, Others) and By End User (Hospitals, Diagnostic Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 2.66% - **2024:** $ 181.5 Million - **2025:** $ 186.33 Million - **2035:** $ 242.25 Million - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Hitachi Medical Corporation (JP), Bracco Imaging S.p.A. (IT), Medtronic (US) **Report ID:** MRFR/HC/51314-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-perfusion-radiology-market-53075 --- ## Market Summary ## **China Perfusion Radiology Market Overview** As per MRFR analysis, the China Perfusion Radiology Market Size was estimated at 234 (USD Million) in 2023. The China Perfusion Radiology Market Industry is expected to grow from 242(USD Million) in 2024 to 354 (USD Million) by 2035. The China Perfusion Radiology Market CAGR (growth rate) is expected to be around 3.518% during the forecast period (2025 - 2035). ### **Key China Perfusion Radiology Market Trends Highlighted** The China Perfusion Radiology Market is experiencing significant growth driven by various market factors. The increasing prevalence of chronic diseases such as cardiovascular conditions and cancer has underscored the need for advanced diagnostic techniques, thereby boosting the demand for perfusion imaging technologies. With the Chinese government prioritizing healthcare improvements and the integration of advanced medical technologies into healthcare infrastructure, there is a strong push for innovation within radiology. Additionally, the Rising investments in healthcare infrastructure and the expansion of regional hospitals equipped with modern imaging capabilities are enhancing access to perfusion radiology services in both urban and rural areas. There is an opportunity to explore the integration of artificial intelligence (AI) in perfusion imaging, which can lead to enhanced diagnostic accuracy and workflow efficiency. AI algorithms can help in analyzing imaging data, thereby driving better patient outcomes and optimizing resource allocation. Furthermore, with China's aging population, the need for regular medical screening and monitoring is expected to rise, reinforcing the value of non-invasive techniques offered by perfusion radiology. Recent trends indicate a growing focus on training and development of healthcare professionals in using advanced imaging technologies. The rise of tele-radiology services is also shaping the way perfusion radiology services are delivered, making it easier for patients to access expert consultations regardless of their location. The emphasis on patient-centered care and the ongoing health reforms in China are supporting the adoption of innovative perfusion techniques, impacting the future trajectory of the market. As China continues to develop its healthcare system, the perfusion radiology market is likely to evolve, capturing new innovations and technologies to improve diagnostic capabilities. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **hina Perfusion Radiology Market Drivers** ### **Increasing Prevalence of Chronic Diseases** In China, the rising incidence of chronic diseases, including cardiovascular diseases and cancer, is significantly driving the China Perfusion Radiology Market Industry. According to the National Health Commission of China, cardiovascular diseases accounted for 40% of deaths in 2020, reflecting a gradual upward trend in chronic disease mortality. Moreover, there has been a notable increase in cancer diagnoses, with statistics suggesting a rise of approximately 11% over the last five years, leading to greater demand for advanced medical imaging technologies that aid in early diagnosis and treatment planning. Companies like Siemens Healthineers and GE Healthcare are heavily investing in Research and Development of innovative perfusion imaging technologies to cater to this growing need, thus propelling market growth. ### **Technological Advancements in Imaging Techniques** The China Perfusion Radiology Market Industry is being significantly influenced by rapid technological advancements in imaging techniques such as magnetic resonance perfusion imaging and computed tomography perfusion imaging. The Chinese government is actively promoting innovation in the medical imaging field, evident from the 'Healthy China 2030' initiative, which aims to integrate modern medical technology into healthcare practices. The National Medical Products Administration has approved numerous state-of-the-art imaging devices in recent years. This trend not only enhances diagnostic accuracy but also expands the application range of perfusion imaging, drawing attention from leading firms like Philips Healthcare, which are keen on enhancing perfusion imaging capabilities. ### **Growing Investments in Healthcare Infrastructure** China's ongoing expansion of its healthcare infrastructure is serving as a crucial driver for the China Perfusion Radiology Market Industry. Data from the Chinese Ministry of Finance indicates that healthcare expenditure has increased by over 9% annually, with significant investments in upgrading hospital facilities and medical equipment. Additionally, the government is emphasizing the development of advanced diagnostic imaging centers across urban and rural areas, improving accessibility to perfusion radiology services. As a result, this surge in healthcare investments attracts global players like Canon Medical Systems Corporation, focusing on establishing their presence in the Chinese market and advancing the overall capabilities of perfusion imaging. ## **China Perfusion Radiology Market Segment Insights** ### **Perfusion Radiology Market Application Insights** Driven by the rising need for sophisticated imaging technologies in many applications, the China Perfusion Radiology Market is seeing strategic expansion. Especially important in improving diagnostic accuracy and patient management is the Application section, which includes Cardiovascular Imaging, Ventilation Imaging, Brain Imaging, and other related fields. Emphasizing Cardiovascular Imaging, its relevance derives from the growing incidence of cardiovascular disorders in China, which calls for exact imaging to guide therapeutic decisions. Often, the complexity of heart diseases calls for high-resolution imaging, which can greatly affect patient results. Ventilation Imaging is important, meantime, for judging pulmonary function and diagnosing respiratory diseases, which are growingly relevant in cities with higher pollution levels. The increase in chronic respiratory disorders underlines the requirement of exact imaging technologies that may help improve treatment judgments. In the field of Brain Imaging, the increasing frequency of neurological diseases and strokes has heightened the need for advanced imaging technologies that allow quick detection and treatment. Critical in a fast-aging population, this sub-segment helps to assess illness development and clarify cerebral perfusion impairments. Reflecting a wide range of needs across patient demographics in China, other uses in this area likewise tackle various healthcare issues. These applications together provide the China Perfusion Radiology Market statistics, therefore highlighting a trend toward more integrated imaging solutions that incorporate several modalities for enhanced diagnostic capabilities. The segmentation of the market shows notable possibilities as technology developments combined with increasing healthcare spending seek to improve the quality and availability of radiology services all over the area, therefore supporting a more efficient and effective healthcare system in China. The continuous Research and Development initiatives inside these applications will also probably open the path for creative imaging technologies, thereby driving the market ahead in the face of increasing focus on patient-centric care strategies and individualized medicine. All things considered, the Application sector is set to expand to meet the important healthcare needs of the Chinese population and to fit the changing healthcare scene, which supports ongoing improvements in perfusion radiology techniques. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Perfusion Radiology Market End User Insights** The China Perfusion Radiology Market showcases a diverse array of End Users, including Hospitals, Diagnostic Centers, and Others, which collectively drive the growth of this vital industry. Hospitals are emerging as critical players due to their extensive patient base and advanced imaging technologies, often serving as the primary location for complex diagnostic procedures. These institutions invest significantly in equipment and training, thereby improving patient outcomes through enhanced imaging capabilities. Diagnostic Centers also represent a substantial portion of the market, as they provide specialized services that cater to the growing demand for precise and timely analysis in a more accessible setting. The proliferation of these centers across urban areas supports increased patient outreach and facilitates early disease detection. Additionally, the 'Others' category, which encompasses research institutions and mobile imaging services, is becoming increasingly relevant, given the rising trend of personalized medicine and the growing need for on-the-go diagnostic solutions. This segmentation highlights the importance of optimizing resource allocation and service delivery across varied healthcare settings, which is essential for maintaining quality standards in diagnostic imaging in China, a nation recognized for its rapid advancements in healthcare technology. ## **China Perfusion Radiology Market Key Players and Competitive Insights** The China Perfusion Radiology Market has been witnessing significant growth driven by advancements in imaging technologies and an increasing prevalence of [chronic disease management](../../../reports/chronic-disease-management-market-981)that require sophisticated diagnostic techniques. The competitive landscape of this market is characterized by the presence of both domestic and international players, resulting in a dynamic environment where innovation and strategic collaborations play a vital role in shaping the market. Companies that specialize in perfusion imaging and related technologies are continuously evolving their offerings to meet the diverse needs of healthcare providers. The competition is primarily focused on enhancing imaging precision, reducing procedure times, and improving patient outcomes, which have become critical benchmarks for success in this sector. Focusing on creating high-quality imaging solutions suited to particular regional healthcare needs, Sky Imaging has carved out a remarkable niche in the China Perfusion Radiology Market. A strong dedication to research and development has helped the corporation to stand against rivals by providing new imaging technologies that are efficient and successful in diagnosing certain medical disorders. Sky Imaging has been able to create a strong network and make headway in several areas of the healthcare sector by focusing on customer service and working with local hospitals and healthcare providers. Its regional focus on product development and marketing tactics helps Sky Imaging to meet the particular demands of the Chinese market while always improving the performance of its imaging equipment. Siemens Healthineers holds a significant share in the China Perfusion Radiology Market, driven by its extensive portfolio of diagnostic imaging products and services. The company is recognized for its cutting-edge technology in magnetic resonance imaging (MRI) and computed tomography (CT), which are essential components of perfusion imaging. Siemens Healthineers has made strategic investments in expanding its infrastructure and partnerships within the Chinese healthcare sector, facilitating access to innovative imaging solutions. The company’s strengths stem from its continuous pursuit of innovation, resulting in advanced imaging systems designed to improve workflow efficiency and diagnostic accuracy. Siemens Healthineers also actively engages in mergers and acquisitions to enhance its capabilities and expand its market presence, making it a significant player in China's evolving healthcare landscape, particularly in the domain of perfusion radiology. The combination of their strong reputation, comprehensive service offerings, and commitment to addressing local healthcare challenges positions Siemens Healthineers advantageously within this competitive arena. ## **Key Companies in the China Perfusion Radiology Market Include** ## **China Perfusion Radiology Market Industry Developments** The China Perfusion Radiology Market has recently witnessed several significant developments. In March 2023, Siemens Healthineers announced enhancements to its innovative imaging solutions aimed at improving the efficiency of perfusion studies across major hospitals in China. Mindray has also introduced advanced AI-based technologies to enhance diagnostic accuracy in perfusion imaging. In April 2023, Canon Medical Systems unveiled a new CT system designed specifically for cardiac imaging, further solidifying its presence in the market. Recent valuation growth in companies such as GE Healthcare and Shanghai United Imaging Healthcare has been noted, reflecting an an increasing demand for precision radiology and imaging technologies. Mergers and acquisitions have also shaped the landscape; for instance, Fujifilm Holdings completed the acquisition of a regional imaging company in October 2023, which is expected to broaden its market share in China. Furthermore, governmental support for health technology innovation has played a pivotal role in driving advancements in the perfusion radiology sector, emphasizing investments in Research and Development by domestic companies like Shenzhen New Industries Biomedical Engineering Co. and ZONARE Medical Systems to solidify their foothold. ## **China Perfusion Radiology Market Segmentation Insights** ### **Perfusion Radiology Market Application Outlook** ### **Perfusion Radiology Market End User Outlook** ## Market Drivers ### Growing Aging Population China's demographic shift towards an aging population is another critical factor influencing the perfusion radiology market. By 2025, it is projected that over 300 million individuals in China will be aged 60 and above. This demographic is particularly susceptible to various health issues, including cardiovascular diseases and strokes, which require effective diagnostic imaging solutions. As the elderly population grows, healthcare providers increasingly adopt perfusion radiology techniques to address their specific needs. The demand for non-invasive imaging methods that can provide detailed insights into blood flow and tissue perfusion is likely to surge. Consequently, this trend may drive investments in advanced imaging technologies and training for healthcare professionals, further propelling the growth of the perfusion radiology market in China. ### Increased Healthcare Expenditure China's rising healthcare expenditure is a significant driver for the perfusion radiology market. The government has been increasing its healthcare budget, aiming to improve access to advanced medical technologies and services. In recent years, healthcare spending has grown at an annual rate of approximately 10%, reflecting the government's commitment to enhancing healthcare quality. This increase in funding allows hospitals and clinics to invest in state-of-the-art imaging equipment, including those used in perfusion radiology. As healthcare facilities upgrade their technologies, the demand for perfusion imaging services is expected to rise. Furthermore, the growing awareness among patients regarding the importance of early diagnosis and treatment is likely to contribute to the increased utilization of perfusion radiology services, thereby driving market growth. ### Focus on Research and Development The emphasis on research and development (R&D) in medical imaging is another vital driver for the perfusion radiology market. In China, numerous research institutions and universities are actively engaged in developing innovative imaging techniques and technologies. This focus on R&D is likely to lead to the introduction of new perfusion imaging modalities that enhance diagnostic capabilities. Collaborations between academic institutions and healthcare providers are fostering an environment conducive to innovation, which may result in improved imaging solutions tailored to the needs of the Chinese population. As new technologies emerge, they could potentially expand the applications of perfusion radiology, making it an indispensable tool in clinical practice. This ongoing commitment to R&D is expected to play a crucial role in shaping the future of the perfusion radiology market. ### Technological Integration in Healthcare The integration of advanced technologies, such as artificial intelligence (AI) and machine learning, is transforming the perfusion radiology market. In China, hospitals are increasingly adopting AI-driven imaging solutions to enhance diagnostic accuracy and efficiency. These technologies can analyze perfusion data more rapidly and accurately than traditional methods, leading to quicker clinical decisions. The Chinese government has been promoting the use of AI in healthcare, which is likely to accelerate the adoption of these technologies in perfusion radiology. As a result, the market may witness a surge in demand for AI-enhanced imaging systems, which could improve patient outcomes and streamline workflows in medical facilities. This technological evolution appears to be a key driver for the growth of the perfusion radiology market, as it aligns with the broader trend of digital transformation in healthcare. ### Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases in China primarily drives the perfusion radiology market. According to recent health statistics, cardiovascular diseases account for approximately 40% of all deaths in the country. This alarming trend necessitates advanced diagnostic tools, such as perfusion imaging, to facilitate early detection and treatment. As healthcare providers seek to improve patient outcomes, the demand for perfusion radiology services is expected to rise significantly. Furthermore, the Chinese government has been investing heavily in healthcare infrastructure, which includes the acquisition of advanced imaging technologies. This investment is likely to enhance the capabilities of hospitals and clinics, thereby expanding the perfusion radiology market. The integration of these technologies into routine clinical practice may lead to improved diagnostic accuracy and better management of cardiovascular conditions. ## Future Outlook The [Perfusion Radiology Market](https://www.marketresearchfuture.com/reports/perfusion-radiology-market-8419) in China is projected to grow at a 2.66% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare investments. **New opportunities:** - Development of AI-driven imaging analysis tools - Expansion of tele-radiology services for remote diagnostics - Partnerships with healthcare providers for integrated imaging solutions By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Ventilation and Cardiovascular Imaging (Largest) vs. Brain Imaging (Fastest-Growing) In the China perfusion radiology market, ventilation and cardiovascular imaging dominate the application segment, capturing the largest share among various imaging modalities. This is due to its critical role in managing respiratory and heart conditions, making it essential for hospitals and clinics across the region. On the other hand, brain imaging, while currently smaller in market share, is rapidly gaining traction as a result of increased awareness and advancements in neuroscience. The growing need for effective brain diagnostic techniques is pushing its adoption in medical practices. The growth trends in this segment are shaped by several factors, including technological advancements and an aging population that demands more specialized imaging solutions. The rising prevalence of cardiovascular diseases and respiratory disorders underlines the importance of ventilation and cardiovascular imaging, while brain imaging benefits from innovations in MRI and CT technologies. As healthcare providers increasingly invest in advanced imaging solutions, both segments are expected to expand, although brain imaging is projected to grow at a faster pace due to its evolving nature and the need for precise diagnostic capabilities. Ventilation and Cardiovascular Imaging (Dominant) vs. Brain Imaging (Emerging) Ventilation and cardiovascular imaging stands as the dominant segment within the China perfusion radiology market, recognized for its comprehensive capabilities in diagnosing and managing a variety of critical pulmonary and cardiovascular conditions. This segment leverages advanced imaging technologies, enabling healthcare providers to obtain high-resolution images vital for accurate assessment and treatment planning. In contrast, brain imaging is considered an emerging segment, driven by innovative imaging techniques and the growing importance of neurological health. As public awareness about brain conditions rises, this segment is quickly gaining focus among medical practitioners who are integrating sophisticated imaging modalities to enhance diagnostic accuracy and patient outcomes. While ventilation and cardiovascular imaging retains a substantial share, brain imaging's rapid growth reflects its increasing relevance in contemporary healthcare. ### By End-User: Hospitals (Largest) vs. Medical Centers (Fastest-Growing) In the China perfusion radiology market, hospitals dominate the end-user segment, accounting for a significant share due to their extensive infrastructure and resources dedicated to advanced imaging technologies. Medical centers are also contributing to the segment, exhibiting a promising growth trajectory as they increasingly adopt perfusion techniques to enhance diagnostic capabilities. The growth trends in this segment are largely driven by the rising demand for accurate diagnostic procedures and improved patient outcomes. As hospitals and medical centers integrate innovative radiology solutions, the need for better perfusion assessment is becoming apparent, leading to accelerated investments in radiology equipment and training. This indicates a dynamic shift towards more sophisticated imaging capabilities within the healthcare sector. Hospitals (Dominant) vs. Medical Centers (Emerging) Hospitals serve as the dominant players in the China perfusion radiology market, leveraging specialized facilities and skilled personnel to deliver comprehensive diagnostic services. Their large-scale operations enable them to invest in cutting-edge technologies, ensuring they remain at the forefront of medical imaging advancements. Conversely, medical centers are emerging as significant contributors to the market, adapting to the growing demand for precision medicine. They often act as accessible healthcare providers that cater to local communities, driving innovation by adopting newer technologies and practices to facilitate timely and effective diagnostics. As such, the interplay between hospitals and medical centers is crucial in shaping the future landscape of the sector. ## Competitive Benchmarking The perfusion radiology market in China is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diagnostic imaging solutions. Major players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. GE Healthcare (US) emphasizes digital transformation and AI integration in its imaging solutions, while Siemens Healthineers (DE) is known for its robust research and development initiatives aimed at improving imaging accuracy and patient outcomes. Philips Healthcare (NL) is actively pursuing regional expansion and collaborations with local healthcare providers to tailor its offerings to the specific needs of the Chinese market, thereby shaping a competitive environment that prioritizes technological advancement and localized solutions.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to various segments of the healthcare sector. The collective influence of these major companies fosters a competitive atmosphere where innovation and customer-centric strategies are paramount. In October Siemens Healthineers (DE) announced a strategic partnership with a leading Chinese hospital network to implement advanced imaging technologies across its facilities. This collaboration is expected to enhance diagnostic capabilities and streamline patient care processes, reflecting Siemens' commitment to integrating cutting-edge technology into everyday clinical practice. Such partnerships not only bolster Siemens' market position but also signify a trend towards collaborative approaches in healthcare delivery. In September GE Healthcare (US) launched a new AI-driven imaging platform specifically designed for the Chinese market, aimed at improving the speed and accuracy of diagnoses. This initiative underscores GE's focus on leveraging artificial intelligence to enhance clinical workflows and patient outcomes. The introduction of this platform is likely to strengthen GE's competitive edge by addressing the unique challenges faced by healthcare providers in China. In August Philips Healthcare (NL) expanded its manufacturing capabilities in China, investing approximately $50 million in a new facility dedicated to producing advanced imaging systems. This move not only demonstrates Philips' commitment to local production but also aims to reduce lead times and improve supply chain reliability. Such investments are indicative of a broader trend towards localized manufacturing, which is becoming increasingly vital in meeting the demands of the rapidly evolving healthcare landscape. As of November current trends in the perfusion radiology market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing service delivery. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to changing market demands. ## Recent News & Developments The China Perfusion Radiology Market has recently witnessed several significant developments. In March 2023, Siemens Healthineers announced enhancements to its innovative imaging solutions aimed at improving the efficiency of perfusion studies across major hospitals in China. Mindray has also introduced advanced AI-based technologies to enhance diagnostic accuracy in perfusion imaging. In April 2023, Canon Medical Systems unveiled a new CT system designed specifically for cardiac imaging, further solidifying its presence in the market. Recent valuation growth in companies such as GE Healthcare and Shanghai United Imaging Healthcare has been noted, reflecting an an increasing demand for precision radiology and imaging technologies. Mergers and acquisitions have also shaped the landscape; for instance, Fujifilm Holdings completed the acquisition of a regional imaging company in October 2023, which is expected to broaden its market share in China. Furthermore, governmental support for health technology innovation has played a pivotal role in driving advancements in the perfusion radiology sector, emphasizing investments in Research and Development by domestic companies like Shenzhen New Industries Biomedical Engineering Co. and ZONARE Medical Systems to solidify their foothold. ## Report Scope | MARKET SIZE 2024 | 181.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 186.33(USD Million) | | MARKET SIZE 2035 | 242.25(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.66% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Hitachi Medical Corporation (JP), Bracco Imaging S.p.A. (IT), Medtronic (US) | | Segments Covered | Application, End-User | | Key Market Opportunities | Advancements in imaging technologies enhance diagnostic accuracy in the perfusion radiology market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the perfusion radiology market. | | Countries Covered | China | ## Frequently Asked Questions **Q: What was the market valuation of the China perfusion radiology market in 2024?** A: The market valuation was $181.5 Million in 2024. **Q: What is the projected market valuation for the China perfusion radiology market in 2035?** A: The projected valuation for 2035 is $242.25 Million. **Q: What is the expected CAGR for the China perfusion radiology market during the forecast period 2025 - 2035?** A: The expected CAGR is 2.66% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the China perfusion radiology market?** A: Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Hitachi Medical Corporation, Bracco Imaging S.p.A., and Medtronic. **Q: What are the main application segments in the China perfusion radiology market?** A: The main application segments are ventilation and cardiovascular imaging, and brain imaging. **Q: What was the market value for ventilation and cardiovascular imaging in 2024?** A: The market value for ventilation and cardiovascular imaging was $90.75 Million in 2024. **Q: What is the projected market value for brain imaging in 2035?** A: The projected market value for brain imaging in 2035 is $121.125 Million. **Q: Which end-user segments are prominent in the China perfusion radiology market?** A: Prominent end-user segments include hospitals, medical centers, diagnostics, dispensaries, charitable trusts, and laboratories. **Q: What was the market value for hospitals in 2024?** A: The market value for hospitals was $45.0 Million in 2024. **Q: What is the projected market value for laboratories in 2035?** A: The projected market value for laboratories in 2035 is $57.25 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-perfusion-radiology-market-53075*